Etofibrate

DB08983ExperimentalSmall molecule

Etofibrate is a fibrate produced by the combination of clofibrate ester linked to niacin. These components separate in the body slowly allowing for pharmacokinetics similar to controlled-release formulations.

Formula / weight: C₁₈H₁₈ClNO₅ · 363.792 g/mol (avg)

Resolves to

Compound

UNII23TF67G79MCAS31637-97-5ChEMBLCHEMBL358150ChEBI135535PubChem65777KEGGD07187

Clinical / RWD

RxNorm24609ATCC10AB09

Structure

InChIKeyXXRVYAFBUDSLJX-UHFFFAOYSA-NSMILESCC(C)(OC1=CC=C(Cl)C=C1)C(=O)OCCOC(=O)C1=CN=CC=C1

What you can answer from here — as of June 12, 2020

157Drug interactionsStructured to mechanism, not free text

1Marketed productAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 14 drug categories

Which companies are running trials of Etofibrate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account